Carlsmed, Inc. (CARL) Stock Forecast
Data as of Jun 16, 2026Healthcare · Current price $10.77 (-1.99%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Dec 15, 2025 | Ryan Zimmerman | BTIG | $24.00 | +122.8% |
| Aug 18, 2025 | Matt O'Brien | Piper Sandler | $18.00 | +67.1% |
Top Analysts Covering CARL
CARL vs Sector & Market
| Metric | CARL | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.24 | 2.41 |
| Analyst Count | 2 | 8 | 19 |
| Target Upside | +81.2% | +11474.9% | +17.1% |
| P/E Ratio | -4.27 | 4.03 | 31.98 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $16M | $17M | $18M | 3 |
| 2026-09-30 | $18M | $19M | $19M | 1 |
| 2026-12-31 | $71M | $73M | $74M | 3 |
| 2027-03-31 | $21M | $22M | $22M | 1 |
| 2027-06-30 | $23M | $24M | $25M | 2 |
| 2027-09-30 | $25M | $26M | $26M | 2 |
| 2027-12-31 | $29M | $30M | $31M | 1 |
| 2028-03-31 | $29M | $30M | $31M | 1 |
| 2028-06-30 | $33M | $35M | $36M | 1 |
| 2028-09-30 | $34M | $35M | $37M | 1 |
| 2028-12-31 | $45M | $47M | $48M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $-0.42 | $-0.40 | $-0.38 | 1 |
| 2026-09-30 | $-0.41 | $-0.39 | $-0.38 | 1 |
| 2026-12-31 | $-1.56 | $-1.53 | $-1.49 | 3 |
| 2027-03-31 | $-0.37 | $-0.35 | $-0.34 | 1 |
| 2027-06-30 | $-0.37 | $-0.36 | $-0.34 | 1 |
| 2027-09-30 | $-0.36 | $-0.35 | $-0.33 | 1 |
| 2027-12-31 | $-0.39 | $-0.37 | $-0.35 | 1 |
| 2028-03-31 | $-0.40 | $-0.38 | $-0.36 | 1 |
| 2028-06-30 | $-0.33 | $-0.32 | $-0.31 | 1 |
| 2028-09-30 | $-0.24 | $-0.23 | $-0.22 | 1 |
| 2028-12-31 | $-0.23 | $-0.22 | $-0.21 | 1 |
Frequently Asked Questions
What is the analyst consensus for CARL?
The consensus among 2 analysts covering Carlsmed, Inc. (CARL) is Buy with an average price target of $20.67.
What is the highest price target for CARL?
The highest price target for CARL is $24.00, set by Ryan Zimmerman at BTIG on 2025-12-15.
What is the lowest price target for CARL?
The lowest price target for CARL is $18.00, set by Matt O'Brien at Piper Sandler on 2025-08-18.
How many analysts cover CARL?
2 analysts have issued ratings for Carlsmed, Inc. in the past 12 months.
Is CARL a buy or sell right now?
Based on 2 analyst ratings, CARL has a consensus rating of Buy (2.00/5) with a +81.2% upside to the consensus target of $20.67.
What are the earnings estimates for CARL?
Analysts estimate CARL will report EPS of $-0.40 for the period ending 2026-06-30, with revenue estimated at $17M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.